Cannabix Technologies delivers Marijuana Breath Test Hardware to Omega Laboratories Inc.

VANCOUVER, British Columbia, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) reports that it has delivered multiple Cannabix Marijuana Breath Test (“MBT”) units to Omega Laboratories Inc. of Ohio, USA (“Omega Laboratories” or “Omega”) to initiate phased commercialization efforts. The MBT hardware includes Cannabix’s proprietary Breath Collection Unit (BCU) and Breath Cartridges (BC) technology which are designed to collect and preserve breath samples to be analysed with Omega’s Laboratory Developed Test Method to detect delta-9-tetrahydrocannabinol (Δ9-THC), the primary psychoactive component of cannabis, in breath (see Figures 1 and 2). The MBT is focused on “recent use” detection of delta-9 THC as opposed to urine, blood and saliva methods (that can detect delta-9 THC many hours, days, or even weeks after consumption) (1).